These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 15987993)

  • 21. Treatment of squamous cell carcinoma of the head and neck in the metastatic and refractory settings: advances in chemotherapy and the emergence of small molecule epidermal growth factor receptor kinase inhibitors.
    Ahmed SM; Cohen EE
    Curr Cancer Drug Targets; 2007 Nov; 7(7):666-73. PubMed ID: 18045071
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chemotherapy for head and neck cancer: progress and controversy in the management of patients with M0 disease.
    Clark JR; Frei E
    Semin Oncol; 1989 Aug; 16(4 Suppl 6):44-57. PubMed ID: 2669137
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Phase I trial of dacomitinib, a pan-human epidermal growth factor receptor (HER) inhibitor, with concurrent radiotherapy and cisplatin in patients with locoregionally advanced squamous cell carcinoma of the head and neck (XDC-001).
    Prawira A; Brana-Garcia I; Spreafico A; Hope A; Waldron J; Razak AR; Chen EX; Jang R; O'Sullivan B; Giuliani M; Bayley A; Cho J; Wang L; Perez-Ordonez B; Weinreb I; Siu LL; Hansen AR
    Invest New Drugs; 2016 Oct; 34(5):575-83. PubMed ID: 27289242
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Taxanes in cancer of the head and neck.
    Misiukiewicz K; Gupta V; Bakst R; Posner M
    Anticancer Drugs; 2014 May; 25(5):561-70. PubMed ID: 24534821
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Docetaxel in the management of head and neck cancer.
    Caponigro F; Longo F; Perri F; Ionna F
    Anticancer Drugs; 2009 Sep; 20(8):639-45. PubMed ID: 19639668
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Preoperative chemotherapy for patients with advanced head and neck cancer].
    Tsukuda M
    Gan To Kagaku Ryoho; 2001 Nov; 28(12):1806-13. PubMed ID: 11729472
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cetuximab in squamous cell carcinoma of the head and neck.
    Hitt R; Martín P; Hidalgo M
    Future Oncol; 2006 Aug; 2(4):449-57. PubMed ID: 16922611
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Radiotherapy for head and neck squamous cell carcinoma: State of the art and future directions].
    Schick U; Huguet F; Pointreau Y; Pradier O
    Cancer Radiother; 2017 Oct; 21(6-7):498-504. PubMed ID: 28864046
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A multidisciplinary approach to squamous cell carcinomas of the head and neck: an update.
    Bernier J
    Curr Opin Oncol; 2008 May; 20(3):249-55. PubMed ID: 18391622
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Effective analysis of non-surgical combined treatments for laryngeal organ preservation in locally advanced laryngeal carcinoma].
    Yan F; Zhang X; Ma L; Liu M; Chen N; Wang J; Wu W; Huang D
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2016 May; 51(5):372-7. PubMed ID: 27220298
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular targeted therapies in the management of head and neck squamous cell carcinoma: recent developments and perspectives.
    Bozec A; Peyrade F; Milano G
    Anticancer Agents Med Chem; 2013 Mar; 13(3):389-402. PubMed ID: 23092267
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Early investigational drugs that target epidermal growth factor receptors for the treatment of head and neck cancer.
    Ugurluer G; Ozsahin M
    Expert Opin Investig Drugs; 2014 Dec; 23(12):1637-54. PubMed ID: 25134724
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Epidermal Growth Factor Receptor Inhibition in Squamous Cell Carcinoma of the Head and Neck.
    Machiels JP; Schmitz S
    Hematol Oncol Clin North Am; 2015 Dec; 29(6):1011-32. PubMed ID: 26568545
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Recent advances in combined modality therapy for locally advanced head and neck cancer.
    Wirth LJ; Posner MR
    Curr Cancer Drug Targets; 2007 Nov; 7(7):674-80. PubMed ID: 18045072
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Radiotherapy and concurrent chemotherapy for the treatment of locally advanced head and neck squamous cell carcinoma.
    Brizel DM
    Semin Radiat Oncol; 1998 Oct; 8(4):237-46. PubMed ID: 9873101
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Role of Chemotherapy in head and neck cancer].
    Kohno N; Kitahara S
    Gan To Kagaku Ryoho; 2001 Apr; 28(4):448-53. PubMed ID: 11329777
    [TBL] [Abstract][Full Text] [Related]  

  • 37. TPF: a rational choice for larynx preservation?
    Calais G
    Oncologist; 2010; 15 Suppl 3():19-24. PubMed ID: 21036885
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chemotherapy in the management of squamous-cell carcinoma of the head and neck.
    Lamont EB; Vokes EE
    Lancet Oncol; 2001 May; 2(5):261-9. PubMed ID: 11905780
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The role of taxanes for head and neck cancer].
    Kohno N
    Gan To Kagaku Ryoho; 2005 Dec; 32(13):2035-9. PubMed ID: 16352925
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Management of the neck in a randomized trial comparing concurrent chemotherapy and radiotherapy with radiotherapy alone in resectable stage III and IV squamous cell head and neck cancer.
    Lavertu P; Adelstein DJ; Saxton JP; Secic M; Wanamaker JR; Eliachar I; Wood BG; Strome M
    Head Neck; 1997 Oct; 19(7):559-66. PubMed ID: 9323143
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.